Digestion of 125I-labelled plasmin-derived fibrin degradation products by neutrophil lysosomal enzymes

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 4, 1998, Pages 307-313

  Adams, S A ^a   Kelly, S L ^a   Kirsch, R E ^a   Shephard, E G ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

D dimer; Factor XIII; Fibrin; Neutrophil lysosomal enzymes; Plasmin

Indexed keywords

CATHEPSIN G; ELASTASE; FIBRIN DEGRADATION PRODUCT; LYSOSOME ENZYME; PLASMIN; DIAGNOSTIC AGENT; DODECYL SULFATE SODIUM; ENZYME INHIBITOR; FIBRIN; FIBRIN FRAGMENT D; MONOCLONAL ANTIBODY; RADIOACTIVE IODINE; REDUCING AGENT; SPERMIDINE; SPERMINE;

ARTICLE; DIAGNOSTIC VALUE; FIBRINOLYSIS; HUMAN; IMMUNE RESPONSE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN PROCESSING; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; IMMUNOLOGY; ISOELECTRIC POINT; LYSOSOME; METABOLISM; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; TIME; TWO DIMENSIONAL GEL ELECTROPHORESIS; ULTRASTRUCTURE;

ANTIBODIES, MONOCLONAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; IODINE RADIOISOTOPES; ISOELECTRIC POINT; LYSOSOMES; MOLECULAR WEIGHT; NEUTROPHILS; PLASMIN; REDUCING AGENTS; SODIUM DODECYL SULFATE; SPERMIDINE; SPERMINE; TIME FACTORS;

EID: 0031595635     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199806000-00002     Document Type: Article

References (38)

1. Pizzo SV, Schwartz ML, Hill RL, McKee PA. The effect of plasmin on the subunit structure of fibrinogen. J Biol Chem 1972; 247: 636-645.
2. Palabrica T, Lobb R, Furie BC, Aronowitz M, Benjamin C, Hsu YM, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992; 359: 848-851.
3. Nathan CF, Srimal S, Farber C, Sanchez Ekabbash L, Asch A, Gailit J, et al. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix protein and CD11/CD18 integrin. J Cell Biol 1989; 109: 1341-1349.
4. Liles WC, Ledbetter JA, Waltersdorph AW, Klebanoff SJ. Cross-linking of CD18 primes human neutrophils for activation of the respiratory burst in response to specific stimuli: implications for adhesion-dependent physiological responses in neutrophils. J Leuk Biol 1995; 58: 690-697.
5. Adams SA, Froese SP, Green BKW, Commerford PJ, Kirsch RE, Shephard EG, et al. Treatment of acute myocardial infarction with streptokinase does not appear to modulate circulating neutrophil function. Clin Cardiol 1995; 18: 459-463.
6. Ranjadayalan K, Umachandran V, Davies SW, Syndercombe-Court D, Gutteridge CN, Timmis AD. Thrombolytic treatment in acute myocardial infarction: neutrophil activation, peripheral leukocyte responses, and myocardial injury. Br Heart J 1991; 66: 10-14.
7. Sylven C, Chen J, Bergstrom K, Bjorkman L, Wallin R, Saldeen T. Fibrin(ogen)-derived peptide Bβ 30-43 is a sensitive marker of activated neutrophils during fibrinolytic treated acute myocardial infarction in man. Am Heart J 1992; 124: 841-846.
8. Bach-Gansmo ET, Halvorsen S, Godal HC, Skjonsberg OH. D-dimers are degraded by human neutrophil elastase. Thromb Res 1996; 82: 177-186.
9. Leavell KJ, Petersen MW, Gross TJ. The role of fibrin degradation products in neutrophil recruitment to the lung. Am J Resp Cell Mol Biol 1996; 14: 53-60.
10. Atencio AC, Burdick DC, Reeve EB. An accurate isotope dilution method for measuring plasma fibrinogen. J Lab Clin Med 1965; 66: 137-145.
11. Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096.
12. Fraker PJ, Speck Jr JC. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun 1978; 80: 849-857.
13. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g. Scand J Clin Lab Invest 1968; 21: 77-81.
14. Bentwood BJ, Henson PM. The sequential release of granule constituents from human neutrophils. J Immunol 1980; 124: 855-862.
15. Shephard EG, Anderson R, Beer SM, Jansen van Rensburg CE, de Beer FC. Neutrophil lysosomal degradation of human CRP: CRP-derived peptides modulate neutrophil function. Clin Exp Immunol 1988; 73: 139-145.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970; 227: 680-685.
17. Towbin H, Staehelin T, Gordon T. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets, procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4354.
18. Andrews AT. Electrophoresis: theory, techniques and biochemical and clinical applications. In: Peacock AR, Harrington WR (editors). Monographs on physical biochemistry, 2nd edition. Oxford: Science Publications, 1986.
19. Strachan AF, de Beer FC, van der Westhuyzen DR, Coetzee GA. Identification of three isoform patterns of human serum amyloid A protein. Biochem J 1988; 250: 203-207.
20. Bangalore N, Travis J. Comparison of properties of membrane bound versus soluble forms of human leukocyte elastase and cathepsin G. Biol Chem Hoppe-Seyler 1994; 375: 659-666.
21. Owen CA, Campbell MA, Sannes PL, Boukedes SS, Campbell EJ. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J Cell Biol 1995; 131: 775-789.
22. Weitz JI, Huang AJ, Landman SL, Nicholson SL, Silverstein SC. Elastase mediated fibrinogenolysis by chemoattractant-stimulated neutrophils occurs in the presence of physiologic concentrations of antiproteinases. J Exp Med 1987; 166: 1836-1850.
23. Weisel JW, Nagaswami C, Korsholm B, Petersen LC, Suenson E. Interactions of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy. J Mol Biol 1994; 235: 1117-1135.
24. Mary A, Achyuthan KE, Greenberg CS. Factor XIII binds to the A-alpha and B-beta chains in the D-domain of fibrinogen: an immunoblotting study. Biochem Biophys Res Commun 1987; 147: 608-614.
25. Hornyak TJ, Bishop PD, Shafer JA. Alpha-thrombin-catalysed activation of human platelet factor XIII: relationship between proteolysis and factor XIIIa activity. Biochemistry 1989; 28: 7326-7332.
26. Conery BG, Berliner LJ. Binding subsites in human thrombins. Biochemistry 1983; 22: 369-375.
27. Laudano AP, Cottrell BA, Doolittle RF. Synthetic peptides modeled on fibrin polymerization sites. Ann NY Acad Sci 1983; 408: 315-329.
28. Declerck PJ, Mombaerts P, Holvoet P, De Mol M, Collen D. Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep vein thrombosis. Thromb Haemost 1987; 58: 1024-1029.
29. Bounameaux H, Cirafici P, de Moerloose P, Schneider P-A, Slosman D, Reber G, et al. Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet 1990; 337: 196-200.
30. Lew AS, Berberian L, Cercek B, Lee S, Shah PK, Ganz W. Elevated serum D-dimer: a degradation product of cross-linked fibrin after intravenous streptokinase during acute myocardial infarction. J Am Coll Cardiol 1986; 7: 1320-1324.
31. Jude B, Amrouni N, Deguine I, Marey A, Asseman P, Watel A, et al. Coupled D-dimer and fibrinogen levels during thrombolytic therapy of venous thromboembolism. Thromb Res 1992; 65: 457-462.
32. Lassila R, Peltonen S, Lepantalo M, Saarinen O, Kauhanen P, Manninen V. Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. Arterioscler Thromb 1993; 13: 1738-1742.
33. Legnani C, Pancani C, Palareti G, Guazzaloca G, Fortunato G, Grauso F, et al. Comparison of new rapid methods for D-dimer measurement to exclude deep vein thrombosis in symptomatic outpatients. Blood Coag Fibrinol 1997; 8: 296-302.
34. Sato N, Takahashi H, Shibbata A. Fibrinogen/fibrin degradation products and D-dimer in clinical practice: interpretation of discrepant results. Am J Hematol 1995; 48: 168-174.
35. Kazura JW, Wenger JD, Salata RA, Budzynski AZ, Goldsmith GH. Modulation of polymorphonuclear microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E. J Clin Invest 1989; 83: 1916-1924.
36. Fischer EG, Vogel P, Ziegler AS, Kirkpatrick CJ. Effect of fibrinogen fragments D and E on the adhesive properties of human granulocytes to venous endothelial cells. Haemostasis 1991; 21: 141-146.
37. Thompson WD, Smith EB, Stirk CM, Marshall FI, Stout AJ, Kochhar A. Angiogenic activity of fibrin degradation products is located in fibrin fragment E. Eur J Pathol 1992; 168: 47-53.
38. Stirk CM, Kochhar A, Smith EB, Thompson WD. Presence of growth-stimulating fibrin degradation products containing fragment E in human atherosclerotic plaques. Atherosclerosis 1993; 103: 159-169.